ArmiƱon, Charito D.
HRN: 24-07-17 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/08/2023
CEFTRIAXONE 1G (VIAL)
11/08/2023
11/14/2023
IVTT
1g
Q12
Osteomyelitis
Checking Final Appropriateness
Indication: Empiric Type of Infection: Bone & JointSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes